Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Tang, Guilin  [Clear All Filters]
Journal Article
Saini N, Bashir Q, Milton DR, Tang G, Delgado R, Rondon G, Popat UR, Hosing CM, Nieto Y, Kebriaei P, et al. Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM. Blood Adv. 2020;4(19):4834-4837.
Shen J, L Medeiros J, Li S, Wang SA, Lin P, Khanlari M, Iyer SP, C Yin C, Tang G, Jorgensen JL, et al. CD8 expression in anaplastic large cell lymphoma (ALCL) correlates with non-common morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative ALCL. Hum Pathol. 2020.
Jain P, Zhang S, Kanagal-Shamanna R, Ok CYoung, Nomie K, Gonzalez GNogueras, Gonzalez-Pagan O, Hill HA, Lee HJu, Fayad L, et al. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv. 2020;4(6):1038-1050.
Li S, Weiss VL, Wang XJ, Desai PA, Hu S, C Yin C, Tang G, Reddy NM, L Medeiros J, Lin P. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol. 2015.
Varma A, Sui D, Milton DR, Tang G, Saini N, Hasan O, Mukherjee A, Joseph JJoy, Bashir Q, Rondon G, et al. Outcome of Multiple Myeloma With Chromosome 1q Gain and 1p Deletion After Autologous Hematopoietic Stem Cell Transplantation: propensity-score matched analysis: Outcome of 1q+/1p- MM pts after auto-HCT. Biol Blood Marrow Transplant. 2019.
Yabe M, L Medeiros J, Tang G, Wang SA, Ahmed S, Nieto Y, Hu S, Bhagat G, Oki Y, Patel KP, et al. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol. 2016.
Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, C Yin C, Seegmiller A, Jorgensen JL, et al. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget. 2016.
Wilson NR, Fang H, Loghavi S, Wang W, Tang G, Haltom RO, Rausch CR, McClain KL, Rao KV, Popat UR, et al. Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. Br J Haematol. 2020.